Akademisyen
SÜMERYA DURU BİRGİ
DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)
ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Radyasyon Onkolojisi
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 41
- Proje 0
- Kitap 0
- Bildiri 88
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
15
Q2
9
Q3
3
Q4
8
WoS (JCR)
Q1
12
Q2
7
Q3
6
Q4
9
TR Index
8
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
54.1%
Üst %1 payı
0.0%
Üst %10 payı
2.9%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study YÖKSİS SJR Q2 JCR Q3 OpenAlex 29.9%
- 2025 Outcomes and prognostic markers in locally advanced head and neck squamous cell carcinoma underwent chemoradiotherapy YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.0%
- 2025 Limitations in Adjuvant Chemoradiotherapy Study YÖKSİS SJR Q1 JCR Q1 OpenAlex 18.1%
- 2024 Radiotherapy Results in Locally Advanced Sinonasal Cancer;Turkish Society for Radiation Oncology, Head and Neck Study Group 01-005 YÖKSİS SJR Q3 JCR Q4 OpenAlex 77.3%
- 2023 Dosimetric investigation of radiation‐induced trigeminal nerve toxicity in parotid tumor patients YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.8%
- 2023 Current Status of Stereotactic Radiotherapy in Türkiye: Turkish Society for Radiation Oncology Stereotactic Radiotherapy Study Group 10-006 Survey YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 14.8%
- 2023 Evaluation of Nutritional Status in Cancer Patients Underwent Radiotherapy: The Results of Biochemical, Body Composition with Bioelectrical Impedance Analysis, Anthropometric Measurements, and Patient-Generated Subjective Global Assessment YÖKSİS TR Index SJR Q4 OpenAlex 22.6%
- 2022 Radyasyon Onkolojisinde Yapay Zeka YÖKSİS OpenAlex 71.2%
- 2025 Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study YÖKSİS SJR Q2 JCR Q3 OpenAlex 29.9%
- 2025 Radiotherapy Outcomes of the National Protocol in Childhood Neuroblastomas: Turkish Society for Radiation Oncology Hematological Oncology, Pediatric Oncology, and TBI Working Group Study (TROD 03-004) YÖKSİS SJR Q1 JCR Q1 OpenAlex 36.4%
- 2025 Outcomes and prognostic markers in locally advanced head and neck squamous cell carcinoma underwent chemoradiotherapy YÖKSİS SJR Q2 JCR Q3 OpenAlex 58.9%
- 2025 Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinoma YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.5%
- 2025 Radiotherapy and Immunotherapy Combinations in Head and Neck Cancers: Clinical Perspectives from Radiation Oncology YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 63.8%
- 2024 Dosimetric evaluation of dysphagia in early stage larynx cancer treated with definitive radiotherapy YÖKSİS SJR Q1 JCR Q1 OpenAlex 56.1%
- 2024 Assessment of Treatment Outcomes and Chest Wall Toxicity Following Stereotactic Body Radiotherapy for Lung Nodules Adjacent to the Pleura YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.5%
- 2024 Radiotherapy Results in Locally Advanced Sinonasal Cancer Turkish Society for Radiation Oncology Head and Neck Study Group 01-005 YÖKSİS SJR Q3 JCR Q4 OpenAlex 77.3%
- 2024 Long-term outcomes of intensity-modulated radiotherapy in limited-stage small-cell lung cancer classified according to AJCC 8th tumor node metastasis staging system YÖKSİS SJR Q2 JCR Q2 OpenAlex 5.6%
- 2024 Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002) YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.4%
- 2024 The Effect of Bladder Volume on Three-dimensional Vaginal Cuff Brachytherapy Planning YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 37.4%
- 2023 EP08.02-11 Dosimetric Contribution of LAD Sparing Radiotherapy Plan in Patients with Postoperative Lung Cancer YÖKSİS SJR Q1 JCR Q1